Can Independent ID Work? Scenario Model
Test the levers side by side — adding an APP, opening infusion, changing hospital volume, shifting payer mix, adding a provider.
Illustrative assumptions. Default values here are example inputs for demonstration only — not validated reimbursement rates, costs or benchmarks. Replace every field with your own practice’s figures.
Biggest single lever
Open or grow infusion
+$21,320 per month against a base of $13,180.
Every scenario, against base
Infusion volume changes by the percentage you set, at unchanged contribution per infusion.
Contribution $34,500/mo · 54% from contracted and ancillary
Contracted income for stewardship, prevention and coverage rises to the monthly figure you set.
Contribution $21,180/mo · 49% from contracted and ancillary
One additional APP absorbing outpatient follow-up, at the visit volume you set.
Contribution $18,647/mo · 42% from contracted and ancillary
Consult volume changes by the percentage you set — the lever you least control.
Contribution $7,872/mo · 48% from contracted and ancillary
Realised revenue per clinical encounter changes by the percentage you set.
Contribution $7,190/mo · 49% from contracted and ancillary
One more physician at the practice's current per-physician consult and clinic productivity.
Contribution $4,405/mo · 43% from contracted and ancillary
How to read this
Scenarios are independent, not cumulative — each applies one change to the same base so the comparison is like-for-like. The useful finding is usually not the biggest bar; it is whether the levers you actually control beat the ones you do not. Hospital consult volume sits with the institution. Pricing your institutional work, and the economics of your infusion business, sit with you.
Every figure here is one you entered. This model publishes no reimbursement rates, drug costs or benchmarks, and it does not know your payer contracts.
How this is calculated
- Each scenario applies exactly one change to the same base practice and re-runs the full economics model.
- The reported figure is the delta in monthly contribution against that base, so scenarios are directly comparable.
- Results are sorted by impact, and shown on a diverging bar so negative scenarios read as clearly as positive ones.
What it does not do
- Scenarios are independent, not cumulative — you cannot read two bars together as a combined plan.
- It assumes a new provider or an expanded infusion service can be staffed and absorbed; it does not model the ramp, the hiring market, or the capital required.
- It has no view on whether the volume assumptions behind each lever are achievable in your market. That is the part only you can supply.
Now that you have a number
Want to pressure-test this against your actual claims data?
This model is only as good as the assumptions you put into it. Persistex works with independent infectious disease practices on billing, coding and revenue cycle, and a practice review starts from your actual payment and denial data.
Prototype: these routes to a demonstration form. No data is transmitted or stored.
Other tools
Independent ID Practice Economics Calculator
The whole practice in one model: office, hospital, APP and infusion revenue against staffing, drug and overhead cost.
CalculatorInfusion & OPAT Economics Calculator
Drug acquisition, nursing, chair time, supplies and reimbursement across a full course of therapy — by site of care.
DirectoryPayer & Drug Authorization Lookup
A curated route to the authoritative sources: ASP pricing files, HCPCS/J-code updates, coverage determinations, home infusion policy and appeals.
AssessmentPractice Health Check
Score eight signals across revenue cycle, payer mix, referral concentration, authorization performance and infusion economics.